Cashu
Forum Markets Appoints Robert Spake as General Counsel to Navigate Regulatory Landscape
about 1 month ago
Stocks
Health Care
frmm
Forum Markets
NASDAQ: FRMM
+1.93 (+81.43%)
4.3
USD
At close at Apr 17, 20:42 UTC
Overview
Loading chart...
Key Stats
Market Cap
50.72M
Dividend Yield
0.00%
P/E Ratio
-0.11
EPS
-157.83
Revenue
-
Avg. Volume
969.59K
About
What does FRMM do?
180 Life Sciences is a clinical-stage biotechnology company based in Palo Alto, California, focused on developing novel drugs for inflammatory diseases using three platforms, primarily targeting anti-TNF therapies. The company went public on June 7, 2017, and currently employs four full-time staff.
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.